196-210 of 2805
Understanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
Heart MattersUnderstanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
From HCM to ATTR-CM: Rethinking Unexplained Hypertrophy
AudioAbstractsFrom HCM to ATTR-CM: Rethinking Unexplained Hypertrophy
Hallie Blevins, PhD
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
On the Frontlines of MigraineCracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Ashley Baker, MSN, PMHNP
Chia-Chun Chiang, MD
Why Vaccination Strategy Matters: Evidence from COVID-19 Modeling
Clinician's RoundtableWhy Vaccination Strategy Matters: Evidence from COVID-19 Modeling
Improving Home BP Monitoring: Inside the AMA’s Validated Device Listing
Perspectives with the AMAImproving Home BP Monitoring: Inside the AMA’s Validated Device Listing
Alexandria May, PharmD, BCPS
Jennifer Cluett, MD
Recognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
DermConsultRecognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
- advertisement
"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
The Convergence"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
Brian P. McDonough, MD, FAAFP
Jean-Claude Saghbini
Reconnecting With Patients: A Human-Centered Approach to Everyday Practice
Clinician's RoundtableReconnecting With Patients: A Human-Centered Approach to Everyday Practice
Michael Greenberg, MD
Ryan Quigley
"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold
The Convergence"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold
Brian P. McDonough, MD, FAAFP
Matthew Newman
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of SchizophreniaNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Brian P. McDonough, MD, FAAFP
Ahmed Makhlouf, MD
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiersUsing fMRI to Identify Early Alzheimer’s Disease Subgroups
Hamid Abuwarda, PhD, BS
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiersEvaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
Sharon Sha, MD, MS
- advertisement
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
GI InsightsAdvances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Stories in PNH: Case Experiences from the Clinic
Project Oncology®Stories in PNH: Case Experiences from the Clinic
Charles Turck, PharmD, BCPS, BCCCP
Timothy Kubal, MD
Vinod Pullarkat, MD
